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Letters to the Editorbypass and will pull on the patch
and perhaps on the AV valves, pos-
sibly making them leak. There is
usually some atrial septum avail-
able, but if not, I would put the
hole and snare as far lateral as pos-
sible, which should make the pull
on the rest of the repair negligible.
John E. Foker, MD, PhD
on behalf of all authors
Division of Cardiothoracic Surgery
University of Minnesota
Minneapolis, Minn
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j.jtcvs.2012.06.033WILL LOCAL USE OF
ANTIBIOTICS BE ESSENTIAL?
To the Editor:
We appreciate the study by Schim-
mer and colleagues1 on gentamicin-
collagen sponge use for heart surgery.
They demonstrated a reduction of
wound complication after surgery by
gentamicin-collagen sponge use.
We agree with Schimmer and col-
leagues1 and strongly recommend
applying antibiotics directly to the
surgical site. Our previous study was
on the prevention of surgical site in-
fection by antibiotic spraying.2 We
used not only gentamicin but also ce-
fazolin. In our study, the incidence of
deep surgical site infection was
0.50% in 2612 patients. We chose
gentamicin and cefazolin because
they cover the most likely contami-
nants, such as Staphylococcus aureus
and Pseudomonas aeruginosa. In the
study by Schimmer and colleagues,1
S aureus cases were low despite the
use of only gentamicin.
Local use of antibiotics is not ac-
cepted by guidelines for prevention of742 The Journal of Thoracic and Csurgical site infection3 because there
is no strong evidence. The references
of the guidelines did not report better
results thanSchimmer and colleagues.1
In reality, many surgeons apply an-
tibiotics by local spraying or subcuta-
neous injection. We think local use of
antibiotics is an essential method for
postoperative reduction of wound
complications.
Hiroshi Osawa, MD, PhD
Kouan Orii, MD, PhD
Division of Cardiothoracic Surgery
Shimada General Hospital
Chiba, Japan
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j.jtcvs.2012.05.079Reply to the Editor:
We appreciate the kind comments1
on our publication ‘‘Gentamicin-Col-
lagen Sponge Reduces Sternal Wound
Complications After Heart Surgery: A
Controlled, Prospectively Random-
ized, Double-Blind Study’’2 regarding
our results of the routine prophylactic
retrosternal use of a gentamicin-
collagen sponge in patients undergo-
ing cardiac surgery. Our answers to
the 3 points included in the letter to
the Editor are as follows:
1. The most likely contaminants of
deep sternal wound infections
(mediastinitis) in our study were
coagulase-negative staphylococci
(68.4%), gram-negative bacteria
(10.5%), Propionibacterium acnes
(10.5%), and Staphylococcus
aureus (5.3%).2 This microbialardiovascular Surgery c September 201spectrum is similar to that in the
Swedish study by Friberg and col-
leagues,3 in which coagulase-
negative staphylococci formed the
largest group of pathogens. The
number of S aureus cases ac-
counted for 2.4% (1 case) in the
presented study, 21.7% in a Swed-
ish study, and 37.3% in a US
study.4 In our study and the Swed-
ish study, there were no patients
with methicillin-resistant S aureus.
By contrast, methicillin-resistant
S aureus infection was identified
in 10.2% of the microbial isolates
(27.3% of the S aureus cases) in
the US study. The extent to which
the dissimilar microbial spectra
and possible antibiotic resistance
influence the results cannot be
clarified.
2. The guidelines for prevention of
surgical site infections investigating
intraoperative gentamicin implant
before wound closure involve 2
randomized controlled trials.3,5,6
Figure 1 shows that the 2 studies
were combined in a meta-analysis,
and that a statistically significant
difference was found favoring the
gentamicin implant (odds ratio,
0.49; 95% confidence interval,
0.34-0.68; I2 ¼ 0%).6
Engelmann and colleagues7 sum-
marized these 2 studies in 2007
by observing that a slight reduc-
tion in infection was seen, but
the population was too small to
draw a definitive conclusion.
Although the use of topical
antibiotics is controversial, and
they are not used by most car-
diac surgeons, the existing
studies demonstrate a reduction
in the wound infection rate.
More study is warranted
before topical antibiotics can
be recommended as a standard
prophylaxis.7 Our study is a ran-
domized controlled trial and
therefore fulfils this demand
and is a contribution toward
more evidence in the prevention
of surgical site infection.2
FIGURE 1. Meta-analysis of 2 trials comparing the effect in cardiac surgery on surgical site infection incidence of inserting a gentamicin implant before
wound closure versus no insertion of a gentamicin implant. CI, Confidence interval; OR, odds ratio.
Letters to the Editor3. We absolutely agree with Osawa
and Orii1 that in reality many
surgeons use antibiotics locally,
and that antibiotic use plays an
essential part in many different
methods to reduce sternal wound
infection.
Christoph Schimmer, MD
Rainer Leyh, MD, PhD
Department of Cardiothoracic and
Thoracic Vascular Surgery
University of W€urzburg
University Hospital W€urzburg
W€urzburg, GermanyReferences
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j.jtcvs.2012.06.017INTERLEUKIN-6 AND -10 AS
MASTER PREDICTIVE
MEDIATORS OF THE
POSTCARDIOPULMONARY
BYPASS INFLAMMATORY
RESPONSE
To the Editor:
We read with great interest the well-
documented work of Jouan and col-
leagues1 on gene polymorphism and
cytokine plasma levels as predictive
factors of complications after cardio-
pulmonary bypass (CPB). Previous
studies highlighted potential roles of
cytokines (eg, interleukin [IL]-6 and
-10) on post-CPB complications2,3
but without mechanistic explanations
of these elevated productions. The
interesting andwell-documented study
of Jouan and colleagues1 now gives
this mechanistic explanation. Genetic
testing of IL6-572G>C and IL10-
592C>Amight thus be a tool for iden-
tifying patients at the highest risk of
poor tolerance to the post-CPB inflam-
matory response. Another main inter-
est of this study is to bring some
doubts concerning the role (if any) of
other pro- or anti-inflammatory com-
pounds released during CPB, such as
angiogenic growth factors and lipidic
mediators, on post-CPB adverse
effects.4,5 It is clear that IL-6 and IL-
10 now can be considered as themaster
predictive control mediators of the
post-CPB inflammatory response.of Thoracic and Cardiovascular SurgeYves Denizot, PhDa
Nathalie Nathan, MD, PhDb
aUniversite de Limoges
Limoges, France
bService d’Anesthesie Reanimation
Chirurgicale
CHU Dupuytren
Limoges, FranceReferences
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We appreciate the comments of
Denizot and Nathan on our article
‘‘Gene Polymorphisms and Cytokine
Plasma Levels as Predictive Factors
of Complications After Cardiopulmo-
nary Bypass.’’1 However, even if wery c Volume 144, Number 3 743
